A phase I study of the humanized monoclonal anti-epidermal growth factor receptor (EGFR) antibody EMD 72000 (matuzumab) in combination with paclitaxel in patients with EGFR-positive advanced non-small-cell lung cancer (NSCLC)
(Q82808934)
scientific article published on 13 March 2006
scientific article published on 13 March 2006
Language:
other details
| description | scientific article published on 13 March 2006 |
External Links
| (P356) |
10.1093/ANNONC/MDL042
|
| (P698) |
16533873
|